Ventyx Biosciences (VTYX) has provided an announcement.
Ventyx Biosciences, Inc. has struck a deal with notable institutional investors for a private placement, aiming to raise $100 million by selling over 11 million shares at $8.95 each. This strategic move, led by Farallon Capital Management and involving other key players, is set to fund Ventyx’s clinical and preclinical program developments while extending its financial runway into the latter half of 2026. The completion of the deal is contingent on typical closing conditions, with Jefferies LLC and others serving as placement agents, ensuring the shares are registered for public resale in compliance with securities laws.
Learn more about VTYX stock on TipRanks’ Stock Analysis page.
